SEBI Reg. Investment Advisor

Download App

Help Center Subscribe

Recent:

Top Pharma Companies in India by Market Cap

BSE Sensex 77649.00
883.08 (1.15%)

Filter

Top Pharma Companies in India as on Jul-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)
1	Abbott India Ltd.	Q V PT	59,301 Mid Cap	27,768.85 (-0.50%)	38.21	12.49	9.96	17.33	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
2	Neuland Laboratories Ltd.	Q V+ PT	24,197 Small Cap	19,253.05 (2.09%)	66.64	12.97	16.64	37.61	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
3	Apollo Hospitals Enterprise Ltd.	Q V+ PT	1,28,055 Large Cap	8,952.80 (0.52%)	85.79	12.85	-3.49	29.94	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
4	Astrazeneca Pharma India Ltd.	Q V PT	20,174 Small Cap	8,189.70 (1.49%)	107.58	23.29	22.84	15.69	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
5	Divis Laboratories Ltd.	Q V+ PT	1,96,990 Large Cap	7,780 (4.85%)	76.71	11.75	8.67	4.44	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
6	Procter & Gamble Health Ltd.	Q V+ PT	11,088 Small Cap	6,613.65 (-0.99%)	33.92	21.14	4.31	11.97	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
7	Kovai Medical Center & Hospital Ltd.	Q V PT	6,425 Small Cap	5,945.40 (1.26%)	26.28	4.87	14.01	17.17	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
8	Alkem Laboratories Ltd.	Q V+ PT	67,559 Mid Cap	5,669.25 (0.33%)	30.92	4.83	5.71	10.33	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
9	Dr Agarwals Eye Hospital Ltd.	Q V PT	2,444 Small Cap	5,001.20 (-1.12%)	34.87	7.06	17.68	31.54	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
10	Torrent Pharmaceuticals Ltd.	Q V+ PT	1,86,354 Large Cap	4,880.25 (-0.39%)	86.14	22.16	11.80	13.74	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
11	Pfizer Ltd.	Q V PT	21,527 Small Cap	4,754.10 (1.03%)	29.28	5.12	2.39	8.89	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
12	Sanofi Consumer Healthcare India Ltd.	Q V+ PT	10,860 Small Cap	4,734.85 (0.41%)	42.11	24.04	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
13	Sanofi India Ltd.	Q V PT	7,743 Small Cap	3,392.80 (0.91%)	24.99	9.93	-8.74	-7.50	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
14	Ajanta Pharma Ltd.	Q V+ PT	41,675 Mid Cap	3,382.25 (1.39%)	39.47	9.21	13.54	10.92	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
15	Acutaas Chemicals Ltd.	Q V+ PT	27,092 Small Cap	3,308.60 (-0.01%)	68.17	15.53	32.80	16.82	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
16	RPG Life Sciences Ltd.	Q V+ PT	4,765 Small Cap	2,899.80 (0.65%)	41.37	7.87	12.70	21.72	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
17	Glaxosmithkline Pharmaceuticals Ltd.	Q V+ PT	44,744 Mid Cap	2,614 (-1.03%)	43.19	19.6	5.49	17.52	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
18	Mankind Pharma Ltd.	Q V PT	1,08,129 Mid Cap	2,602.05 (-0.61%)	53.07	6.61	13.54	13.36	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
19	Caplin Point Laboratories Ltd.	Q V PT	19,681 Small Cap	2,599.10 (0.38%)	30.69	5.49	17.55	21.52	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
20	Kwality Pharmaceuticals Ltd.	Q V+ PT	2,687 Small Cap	2,556 (-1.29%)	39.89	8.08	21.70	37.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
21	Gland Pharma Ltd.	Q V PT	40,040 Small Cap	2,515.65 (3.64%)	30.81	3.7	9.35	7.37	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
22	Hester Biosciences Ltd.	Q V PT	2,148 Small Cap	2,460.10 (-2.57%)	41.23	5.58	6.98	0.80	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
23	Lupin Ltd.	Q V PT	1,09,494 Mid Cap	2,457.70 (2.63%)	20.53	4.89	13.02	32.37	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
24	Glenmark Pharmaceuticals Ltd.	Q V+ PT	61,658 Mid Cap	2,260 (3.44%)	45.28	5.87	4.60	14.41	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
25	CORONA Remedies Ltd.	Q V+ PT	12,654 Small Cap	2,100.75 (1.54%)	68.45	16.96	19.49	18.67	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
26	Narayana Hrudayalaya Ltd.	Q V PT	42,358 Mid Cap	2,080.75 (0.39%)	52.58	9.34	25.04	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
27	Sun Pharmaceutical Industries Ltd.	Q V+ PT	4,74,397 Large Cap	1,984.45 (0.37%)	41.33	5.68	11.78	14.41	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
28	Wockhardt Ltd.	Q V+ PT	30,660 Small Cap	1,925.35 (2.04%)	143.94	6.22	4.49	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
29	Emcure Pharmaceuticals Ltd.	Q V PT	35,881 Small Cap	1,886.55 (-0.27%)	48.95	9.67	13.02	9.98	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
30	Dr. Lal Pathlabs Ltd.	Q V PT	30,280 Small Cap	1,882.80 (4.24%)	55.58	11.77	12.18	13.26	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 4 5 Next

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Artemis MedicareServ	301.05	8.60%
Divis Laboratories	7,780	4.85%
Suven Life Sciences	308.40	4.81%
SMS Pharmaceuticals	397.50	4.36%
Dr. Lal Pathlabs	1,882.80	4.24%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
Hester Biosciences	2,460.10	-2.57%
Fischer Medical	35.99	-2.31%
3B Blackbio Dx	1,275	-1.63%
Fermenta Biotech	450	-1.37%
Kwality Pharma	2,556	-1.29%

News about Top Pharma Companies in India

Jul, 2026

Gland Pharma gets USFDA’s approval for Sugammadex Injection

According to IQVIA, the product had US sales of approximately $1.6 billion for the twelve months ending April 2026

Jul, 2026

Gland Pharma informs about press release

Gland Pharma has informed that it enclosed press release titled ‘Gland Pharma receivesapproval for Sugammadex Injection 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials.’

The above information is a part of company’s filings submitted to BSE.

Jul, 2026

AstraZeneca Pharma India informs about certificate

AstraZeneca Pharma India has informed that it enclosed the Certificate dated July 27, 2026 issued by Integrated Registry Management Services, Registrar and Transfer Agents (RTA) of the Company confirming the compliance of Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2026.

The above information is a part of company’s filings submitted to BSE.

Jul, 2026

Glenmark Pharmaceuticals rises as its arm launches Sugammadex Injection

Glenmark’s Sugammadex Injection is bioequivalent and therapeutically equivalent to the reference listed drug, BRIDION Injection, 100 mg/mL of Merck Sharp & Dohme LLC

Jul, 2026

Glenmark Pharmaceuticals’ arm launches Sugammadex Injection

Glenmark’s Sugammadex Injection is bioequivalent and therapeutically equivalent to the reference listed drug, BRIDION Injection, 100 mg/mL of Merck Sharp & Dohme LLC

Jul, 2026

Pfizer - Quaterly Results

The company witnessed a 8.31% growth in the revenue at Rs. 6531.70 millions for the quarter ended June 2026 as compared to Rs. 6030.50 millions during the year-ago period.Net profit stood at Rs. 2044.70 millions compared to Rs. 1917.50 millions in the corresponding previous quarter,high by 6.63%.Operating Profit saw a handsome growth to 2924.00 millions from 2771.90 millions in the quarter ended June 2026.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202606	202506	% Var	202606	202506	% Var	202603	202503	% Var
Sales	6531.70	6030.50	8.31	6531.70	6030.50	8.31	25196.50	22813.50	10.45
Other Income	448.40	671.70	-33.24	448.40	671.70	-33.24	1879.50	1722.50	9.11
PBIDT	2924.00	2771.90	5.49	2924.00	2771.90	5.49	10920.40	9124.80	19.68
Interest	14.60	32.50	-55.08	14.60	32.50	-55.08	94.80	84.10	12.72
PBDT	2909.40	2739.40	6.21	2909.40	2739.40	6.21	10334.00	10768.80	-4.04
Depreciation	142.60	144.10	-1.04	142.60	144.10	-1.04	577.30	607.90	-5.03
PBT	2766.80	2595.30	6.61	2766.80	2595.30	6.61	9756.70	10160.90	-3.98
TAX	722.10	677.80	6.54	722.10	677.80	6.54	2532.40	2484.90	1.91
Deferred Tax	12.80	3.90	228.21	12.80	3.90	228.21	-42.80	-156.10	-72.58
PAT	2044.70	1917.50	6.63	2044.70	1917.50	6.63	7224.30	7676.00	-5.88
Equity	457.50	457.50	0.00	457.50	457.50	0.00	457.50	457.50	0.00
PBIDTM(%)	44.77	45.96	-2.61	44.77	45.96	-2.61	43.34	40.00	8.36

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Rank	Company	Market Capitalization 2026 (INR crores)
1	Abbott India Ltd.	59,301 Crore
2	Neuland Laboratories Ltd.	24,197 Crore
3	Apollo Hospitals Enterprise Ltd.	1,28,055 Crore
4	Astrazeneca Pharma India Ltd.	20,174 Crore
5	Divis Laboratories Ltd.	1,96,990 Crore
6	Procter & Gamble Health Ltd.	11,088 Crore
7	Kovai Medical Center & Hospital Ltd.	6,425 Crore
8	Alkem Laboratories Ltd.	67,559 Crore
9	Dr Agarwals Eye Hospital Ltd.	2,444 Crore
10	Torrent Pharmaceuticals Ltd.	1,86,354 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	27,769	59,301	38.21	12.49	26.17	34.24
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,880	1,86,354	86.14	22.16	44.79	29.04
Lupin Ltd. (M)	Somewhat Good	2,458	1,09,494	20.53	4.89	11.88	26.43
Ajanta Pharma Ltd. (M)	Very Good	3,382	41,675	39.47	9.21	26.67	25.35
Alkem Laboratories Ltd. (M)	Very Good	5,669	67,559	30.92	4.83	22.42	17.86

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	1,782	94,987	97.82
Sai Life Sciences Ltd. (S)	Very Good	1,310	27,605	57.56
Aurobindo Pharma Ltd. (M)	Very Good	1,591	89,212	37.52
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,880	1,86,354	35.15
Lupin Ltd. (M)	Somewhat Good	2,458	1,09,494	22.15
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
Sai Life Sciences Ltd. (S)	Very Good	1,310	27,605	80.84	11.01	42.51	17.75
Ajanta Pharma Ltd. (M)	Very Good	3,382	41,675	39.47	9.21	26.67	13.54
Mankind Pharma Ltd. (M)	Very Good	2,602	1,08,129	53.07	6.61	33.20	13.54
Zydus Lifesciences Ltd. (M)	Very Good	1,125	1,09,686	21.76	4.22	13.36	13.52
Lupin Ltd. (M)	Somewhat Good	2,458	1,09,494	20.53	4.89	11.88	13.02

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Lupin Ltd. (M)	Somewhat Good	2,458	1,09,494	20.53	4.89	11.88	32.37
Abbott India Ltd. (M)	Very Good	27,769	59,301	38.21	12.49	26.17	17.33
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,144	94,790	29.42	2.48	15.11	15.75
Zydus Lifesciences Ltd. (M)	Very Good	1,125	1,09,686	21.76	4.22	13.36	14.72
Sun Pharmaceutical Industries Ltd. (L)	Very Good	1,984	4,74,397	41.33	5.68	23.70	14.41

You have 9 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now

Create stable, long-term investment portfolio with strong, consistent stocks.

Start Research-backed Investing ...Now. Subscribe to Sapphire

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

Gland Pharma gets USFDA’s approval for Sugammadex Injection

Gland Pharma informs about press release

AstraZeneca Pharma India informs about certificate

Glenmark Pharmaceuticals rises as its arm launches Sugammadex Injection

Glenmark Pharmaceuticals’ arm launches Sugammadex Injection

Pfizer - Quaterly Results

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?

Create stable, long-term investment portfolio with strong, consistent stocks.

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.